"CVAM is dedicated to excellent cardiac, peripheral vascular and electrophysiology care. Our goal is to provide you with compassionate patient care and service. Due to the growing number of locations outside of Mesa, CardioVascular Associates of Mesa changed their name to CVAM."

During the past decade, Cardiovascular Associates of Mesa conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 6 clinical trials were completed, i.e. on average, 85.7% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 5 clinical trials were completed. i.e. 166.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cardiovascular Associates of Mesa" #1 sponsor was "Boston Scientific Corporation" with 3 trials, followed by "Medtronic Cardiac Rhythm and Heart Failure" with 3 trials sponsored, "Abbott Medical Devices" with 2 trials sponsored, "Impulse Dynamics" with 2 trials sponsored and "Angel Medical Systems" with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cardiovascular Associates of Mesa" #1 collaborator was "Medtronic" with 1 trials as a collaborator and "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Cardiovascular Associates of Mesa" are "Heart Failure" (5 trials), "Primary Prevention of Sudden Cardiac Arrest" (2 trials), "Secondary Prevention of Sudden Cardiac Arrest" (2 trials), "Acute Coronary Syndrome" (1 trials) and "Atrial Fibrillation" (1 trials). Many other conditions were trialed in "Cardiovascular Associates of Mesa" in a lesser frequency.

Most popular intervention types in "Cardiovascular Associates of Mesa" are "Device" (9 trials), "Drug" (3 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Aspirin" (1 trials), "CRT Patients" (1 trials), "Cardiac Contractility Modulation Therapy via OPTIMIZER™ Smart Mini System" (1 trials), "Clopidogrel or Ticagrelor" (1 trials) and "Dabigatran Etexilate 110mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cardiovascular Associates of Mesa" are 15 trials for "All" genders.

Currently, there are NaN active trials in "Cardiovascular Associates of Mesa". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Cardiovascular Associates of Mesa, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Cardiovascular Associates of Mesa, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".